日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Nitrosomonas eutropha Protein RecA (recA) CSB-YP601801NAAD
CSB-EP601801NAAD
CSB-BP601801NAAD
CSB-MP601801NAAD
CSB-EP601801NAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosomonas eutropha N-acetyl-gamma-glutamyl-phosphate reductase (argC) CSB-YP601802NAAD
CSB-EP601802NAAD
CSB-BP601802NAAD
CSB-MP601802NAAD
CSB-EP601802NAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosomonas eutropha Flagellar transcriptional regulator FlhD (flhD) CSB-YP601803NAAD
CSB-EP601803NAAD
CSB-BP601803NAAD
CSB-MP601803NAAD
CSB-EP601803NAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosomonas eutropha Aspartate--tRNA ligase (aspS) CSB-YP601804
CSB-EP601804
CSB-BP601804
CSB-MP601804
CSB-EP601804-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosomonas eutropha 30S ribosomal protein S13 (rpsM) CSB-YP601805NAAD
CSB-EP601805NAAD
CSB-BP601805NAAD
CSB-MP601805NAAD
CSB-EP601805NAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosomonas eutropha 30S ribosomal protein S14 (rpsN) CSB-YP601806NAAD
CSB-EP601806NAAD
CSB-BP601806NAAD
CSB-MP601806NAAD
CSB-EP601806NAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosomonas eutropha 30S ribosomal protein S19 (rpsS) CSB-YP601807NAAD
CSB-EP601807NAAD
CSB-BP601807NAAD
CSB-MP601807NAAD
CSB-EP601807NAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosomonas eutropha 30S ribosomal protein S10 (rpsJ) CSB-YP601808NAAD
CSB-EP601808NAAD
CSB-BP601808NAAD
CSB-MP601808NAAD
CSB-EP601808NAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosomonas eutropha Homoserine O-acetyltransferase (metX) CSB-YP601809NAAD
CSB-EP601809NAAD
CSB-BP601809NAAD
CSB-MP601809NAAD
CSB-EP601809NAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosomonas eutropha 3-oxoacyl-[acyl-carrier-protein] synthase 3 (fabH) CSB-YP601810NAAD
CSB-EP601810NAAD
CSB-BP601810NAAD
CSB-MP601810NAAD
CSB-EP601810NAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosomonas eutropha Orotidine 5'-phosphate decarboxylase (pyrF) CSB-YP601811NAAD
CSB-EP601811NAAD
CSB-BP601811NAAD
CSB-MP601811NAAD
CSB-EP601811NAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosomonas eutropha Protein smg homolog (smg) CSB-YP601812
CSB-EP601812
CSB-BP601812
CSB-MP601812
CSB-EP601812-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosomonas eutropha 30S ribosomal protein S21 (rpsU) CSB-YP601813NAAD
CSB-EP601813NAAD
CSB-BP601813NAAD
CSB-MP601813NAAD
CSB-EP601813NAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosomonas eutropha ATP synthase epsilon chain (atpC) CSB-YP601814NAAD
CSB-EP601814NAAD
CSB-BP601814NAAD
CSB-MP601814NAAD
CSB-EP601814NAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosomonas eutropha D-alanine--D-alanine ligase (ddl) CSB-YP601815NAAD
CSB-EP601815NAAD
CSB-BP601815NAAD
CSB-MP601815NAAD
CSB-EP601815NAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosomonas eutropha Trigger factor (tig) CSB-YP601816NAAD
CSB-EP601816NAAD
CSB-BP601816NAAD
CSB-MP601816NAAD
CSB-EP601816NAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosomonas eutropha UPF0059 membrane protein Neut_0042 (Neut_0042), partial CSB-YP601817NAAD1
CSB-EP601817NAAD1
CSB-BP601817NAAD1
CSB-MP601817NAAD1
CSB-EP601817NAAD1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Maricaulis maris (Dimethylallyl)adenosine tRNA methylthiotransferase MiaB (miaB) CSB-YP601818MAAJ
CSB-EP601818MAAJ
CSB-BP601818MAAJ
CSB-MP601818MAAJ
CSB-EP601818MAAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Maricaulis maris Leucine--tRNA ligase (leuS), partial CSB-YP601819MAAJ
CSB-EP601819MAAJ
CSB-BP601819MAAJ
CSB-MP601819MAAJ
CSB-EP601819MAAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Maricaulis maris Alkyl hydroperoxide reductase AhpD (ahpD) CSB-YP601820MAAJ
CSB-EP601820MAAJ
CSB-BP601820MAAJ
CSB-MP601820MAAJ
CSB-EP601820MAAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×